Stock-Based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2020 |
Share-based Payment Arrangement [Abstract] |
|
Schedule of Stock-Based Compensation Expense |
Stock-based compensation expense consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
(in thousands) |
|
2020 |
|
2019 |
|
2018 |
Cost of sales |
|
$ |
303 |
|
|
$ |
278 |
|
|
$ |
250 |
|
SG&A expense |
|
17,475 |
|
|
17,554 |
|
|
14,041 |
|
Pre-tax stock-based compensation expense |
|
17,778 |
|
|
17,832 |
|
|
14,291 |
|
Income tax benefits |
|
(4,015) |
|
|
(4,009) |
|
|
(3,218) |
|
Total stock-based compensation expense, net of tax |
|
$ |
13,763 |
|
|
$ |
13,823 |
|
|
$ |
11,073 |
|
|
Schedule of Weighted Average Assumptions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2020 |
|
2019 |
|
2018 |
Expected option term |
|
4.39 years |
|
4.50 years |
|
4.50 years |
Expected stock price volatility |
|
21.19% |
|
27.14% |
|
28.39% |
Risk-free interest rate |
|
1.14% |
|
2.49% |
|
2.47% |
Expected annual dividend yield |
|
1.13% |
|
1.03% |
|
1.15% |
Weighted average grant date fair value per share |
|
$14.67 |
|
$22.51 |
|
$18.86 |
|
Summary of Stock Option Activity |
The following table summarizes stock option activity under the Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
Weighted Average Exercise Price |
|
Weighted Average Remaining Contractual Life |
|
Aggregate Intrinsic Value (1)
(in thousands)
|
Options outstanding at January 1, 2018 |
|
1,769,887 |
|
|
$ |
44.22 |
|
|
6.69 |
|
$ |
48,962 |
|
Granted |
|
402,010 |
|
|
76.48 |
|
|
|
|
|
Cancelled |
|
(67,440) |
|
|
60.75 |
|
|
|
|
|
Exercised |
|
(499,836) |
|
|
36.98 |
|
|
|
|
|
Options outstanding at December 31, 2018 |
|
1,604,621 |
|
|
53.86 |
|
|
6.95 |
|
48,703 |
|
Granted |
|
395,653 |
|
|
93.98 |
|
|
|
|
|
Cancelled |
|
(68,275) |
|
|
74.10 |
|
|
|
|
|
Exercised |
|
(452,325) |
|
|
43.76 |
|
|
|
|
|
Options outstanding at December 31, 2019 |
|
1,479,674 |
|
|
66.74 |
|
|
7.11 |
|
49,930 |
|
Granted |
|
660,071 |
|
|
87.25 |
|
|
|
|
|
Cancelled |
|
(78,163) |
|
|
83.76 |
|
|
|
|
|
Exercised |
|
(142,419) |
|
|
48.58 |
|
|
|
|
|
Options outstanding at December 31, 2020 |
|
1,919,163 |
|
|
$ |
74.45 |
|
|
7.19 |
|
$ |
29,489 |
|
Options vested and expected to vest at December 31, 2020 |
|
1,839,590 |
|
|
$ |
73.88 |
|
|
7.12 |
|
$ |
29,185 |
|
Options exercisable at December 31, 2020 |
|
806,320 |
|
|
$ |
60.31 |
|
|
5.53 |
|
$ |
22,620 |
|
|
Schedule Of Weighted Average Assumptions for Restricted Stock Units |
The weighted average assumptions for restricted stock units granted and resulting fair value are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2020 |
|
2019 |
|
2018 |
Vesting period |
|
3.79 years |
|
3.76 years |
|
3.77 years |
Expected annual dividend yield |
|
1.18% |
|
0.97% |
|
1.15% |
Weighted average grant date fair value per restricted stock unit granted |
|
$78.90 |
|
$94.58 |
|
$73.74 |
|
Summary of Restricted Stock Unit Activity |
The following table summarizes the restricted stock unit activity under the Plan:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares
|
|
Weighted Average
Grant Date Fair Value Per Share
|
Restricted stock units outstanding at January 1, 2018 |
|
449,475 |
|
|
$ |
52.07 |
|
Granted |
|
197,299 |
|
|
73.74 |
|
Vested(1)
|
|
(155,847) |
|
|
50.97 |
|
Forfeited |
|
(66,926) |
|
|
53.19 |
|
Restricted stock units outstanding at December 31, 2018 |
|
424,001 |
|
|
62.38 |
|
Granted |
|
177,618 |
|
|
94.58 |
|
Vested(1)
|
|
(163,195) |
|
|
60.45 |
|
Forfeited |
|
(33,320) |
|
|
72.35 |
|
Restricted stock units outstanding at December 31, 2019 |
|
405,104 |
|
|
76.45 |
|
Granted |
|
216,318 |
|
|
78.90 |
|
Vested(1)
|
|
(160,229) |
|
|
68.72 |
|
Forfeited |
|
(35,918) |
|
|
79.36 |
|
Restricted stock units outstanding at December 31, 2020 |
|
425,275 |
|
|
$ |
80.37 |
|
|